Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma: a Single-arm, Multicenter, Phase II Clinical Study

NCT06478264 is registered in ClinicalTrials.gov with Zhangzhou Municipal Hospital as lead sponsor.

NCT NCT06478264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06478264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma: a Single-arm, Multicenter, Phase II Clinical Study
Lead sponsor
Zhangzhou Municipal Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
July 13, 2024
Completion date
July 13, 2027
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal small cell carcinoma